Publication | Closed Access

Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer

Breast OncologyOncologyLiarozole FumarateMedicineBreast CancerPharmacotherapyTamoxifen RefractoryCancer TreatmentPharmacologyEndocrine-related CancerEr Negative